COVID-19 vaccination in our transplant recipients: The time is now.
vaccine, covid-19, Pandemic, SARS-CoV-2, Vaccination, transplant
We are entering 2021 with an expanding and effective COVID-19 vaccine armamentarium. Recent interim results from COVID-19 vaccine trials, including more than 80,000 participants worldwide, demonstrate remarkable efficacy and low rate of serious adverse events. Based on experience with other vaccines in transplant recipients and knowing the risk of severe COVID-19 in this population, we believe that COVID-19 vaccines provide potential benefit with minimal risk. We strongly support and encourage COVID-19 vaccination of our transplant recipients.
Robin Vos, Saima Aslam, Daniel R Goldstein, Andrew E Gelman, Michelle M Kittleson, Cameron Wolfe, Lara Danziger-Isakov
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation